Volume 24 (2021)
Volume 23 (2020)
Volume 22 (2019)
Volume 21 (2018)
Volume 20 (2017)
Volume 19 (2016)
Volume 18 (2015)
Volume 17 (2014)
Volume 16 (2013)
Volume 15 (2012)
Volume 14 (2011)
Volume 13 (2010)
Volume 12 (2009)
Volume 11 (2008)
Volume 10 (2007)
Volume 9 (2006)
Volume 8 (2005)
Volume 7 (2004)
Volume 6 (2002)
Volume 5 (2002)
Volume 4 (2000)
Volume 3 (1999)
Volume 2 (1998)
Volume 1 (1997)
1. Evaluation of the efficacy and safety of rituximab in patients with refractory pemphigus vulgaris

Shahidi-Dadras Mohammad; Kheradmand Zohreh; Abdollahimajd Fahimeh

Volume 21, Issue 2 , 2018, , Pages 48-53

http://dx.doi.org/10.22034/ijd.2018.98351

Abstract
  Background: Recently, rituximab has been successfully used for the treatment of pemphigus family, the main subtype of which is pemphigus vulgaris (PV). The aim of this study was to determine the efficacy and safety of rituximab in refractory PV. Methods: In an observational study extending from November ...  Read More

2. Can we consider erythrocyte sedimentation rate and C-reactive protein as a severity index in pemphigus vulgaris?

Handjani Farhad; Saki Nasrin; Hosseini Motahareh; Tadayon Taraneh

Volume 20, Issue 3 , 2017, , Pages 84-88

Abstract
  Background: Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are 2 inflammatory indicators that increase in many pathologic and physiologic conditions. Pemphigus vulgaris (PV) is an autoimmune skin disease in which autoantibodies against desmogleins cause acantholysis. In this study ...  Read More